Trimi Health in the Press
Coverage and mentions from news and trade publications, with links to the original sources. A media mention is not a clinical endorsement.
Each citation links to the source publication for transparency. Trimi does not edit or pay to remove third-party criticism.
National coverage
GLP-1 Telehealth: From The Access Boom To Regulatory Reckoning
Trimi combines licensed clinical oversight with optimized online workflows for consultation, prescription, and fulfillment.
Read the article on ForbesBank Of America Bucks Downward Trend In Employer Coverage Of GLP-1s For Obesity
Forbes cites Trimi's survey of around 1,000 US adults, 60% say they are willing to incur medical debt to access obesity medication, and describes Trimi as a licensed telehealth provider specializing in compounded GLP-1 weight management medications.
Read the article on ForbesResearch coverage
SEX FILES: Will weight-loss drugs improve your sex life?
Postmedia's Sex Files column cites Trimi's survey, "the weight-loss company Trimi surveyed more than 1,000 adults about what they would give up to access GLP-1 medications", and ran across the Postmedia network, including the Toronto Sun, Vancouver Sun, Calgary Herald, Edmonton Journal, and Ottawa Citizen.
Read the article on Toronto SunEXCLUSIVE: GLP-1 users are switching to these apparel retailers
Retail trade press coverage of the GLP-1 Closet Reset survey, "exclusively released to Chain Store Age by telehealth provider Trimi," on which apparel retailers gain and lose as GLP-1 users resize their wardrobes.
Read the article on Chain Store AgeAmericans are risking their savings for weight-loss drugs
AOL's syndicated finance coverage cites "a Trimi survey of 1,065 U.S. adults" three times on the savings and budget trade-offs Americans accept to start or stay on GLP-1 treatment.
Read the article on AOLGLP-1 costs push users into debt and delayed retirement
TheStreet cited Trimi's survey of 1,065 U.S. adults on the financial trade-offs behind GLP-1 treatment, including patients taking on debt and delaying retirement to stay on medication.
Read the article on TheStreetWeight loss spending becomes a budget priority that consumers may be reluctant to cut
eMarketer's second piece drawing on Trimi research covered the American Weight Loss Budget survey of 1,005 U.S. adults, reporting a $116 average monthly weight-loss spend and treating it as a budget line consumers protect.
Read the article on eMarketerGLP-1 users cut savings and big purchases to stay on treatment
eMarketer's analysts drew on Trimi's survey to report how far GLP-1 users go financially to stay on treatment, noting that the sacrifices underscore relentless demand despite high costs.
Read the article on eMarketerAmericans Want GLP-1s So Badly They’d Give Up Sex for a Year
Telehealth company Trimi surveyed 1,065 U.S. adults about what they’d sacrifice to start or stay on a GLP-1, one in four who use or want a GLP-1 would give up sex, dating, or a romantic relationship for a year before walking away from treatment.
Read the article on VICEWant to reach out?
Trimi welcomes editorial inquiries from health publications, journalists covering compounded GLP-1 telehealth, and independent reviewers. For press inquiries, partnership questions, or interview requests, contact us via the patient-care channel.
Contact Trimi